Rescue revascularization therapy with a stent-in-stent technique for acute intracranial internal carotid artery occlusion - Case report

Neurologia Medico-Chirurgica

Volumn 45, Issue 5, 2005, Pages 253-258

  Okazaki, Toshiyuki ^a   Satomi, Junichiro ^a,b   Satoh, Koichi ^a   Hirasawa, Motohiro ^a   Nagahiro, Shinji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

Acute internal carotid artery occlusion; Intracranial stenting; Stent in stent technique

Indexed keywords

HEPARIN; OZAGREL; TICLOPIDINE; UROKINASE;

ACUTE DISEASE; ADULT; ANAMNESIS; ARTERY THROMBOSIS; ARTICLE; BRAIN ANGIOGRAPHY; CASE REPORT; CORONARY STENT; FEMALE; HEMIPARESIS; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; STROKE;

ACUTE DISEASE; ANGIOPLASTY, BALLOON; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CEREBRAL REVASCULARIZATION; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MIDDLE AGED; STENTS;

EID: 20444386276     PISSN: 04708105     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.45.253     Document Type: Article

References (18)

1. Al-Mubarak N, Gomez CR, Vitek JJ, Roubin GS: Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol 19: 1949-1951, 1998
2. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH: Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 102: 624-629, 2000
3. Brener SJ, Ellis SG, Schneider J, Apperson-Hansen C, Topol EJ: Abciximab-facilitated percutaneous coronary intervention and long-term survival - a prospective single-center registry. Eur Heart J 24: 630-638, 2003
4. The EPISTENT Investigators: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 352: 87-92, 1998
5. Haude M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, Meyer J: Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 126: 15-22, 1993
6. Karrillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier B, Commeau P, Cribier A, Eiferman C, Grollier G, Guerin Y, Henry M, Lefevre T, Livarek B, Louvard Y, Marco J, Makowski S, Monassier JP, Pernes JM, Rioux P, Spaulding C, Zemour G: Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation 94: 1519-1527, 1996
7. Karvouni E, Katritsis DG, Ioannidis JP: Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 41: 26-32, 2003
8. Kaul U, Gupta RK, Haridas KK, Ramesh SS, Sethi KK, Singh B, Agarwal R, Yadave RD, Chose T, Sapra RR, Bajaj R, Shahi M, Bhagwat A, Kumar P, Mathews OP, Soni PK; Integrilin in Acute Myocardial Infarction (INAMI) Stenting Study Investigators: Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study. Catheter Cardiovasc Interv 57: 497-503, 2002
9. Kleiman NS: A risk-benefit assessment of abciximab in angioplasty. Drug Saf 20: 43-57, 1999
10. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C: Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol 23: 430-436, 2002
11. Mayes CE Jr, Kandzari DE, Goldschmidt-Clermont PJ, Phillips HR: The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention. J invasive Cardiol 14 Suppl E: 36E-47E, 2002
12. Moliterno DJ, Chan AW: Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET. J Am Coll Cardiol 41 (4 Suppl S): 49S-54S, 2003
13. Mori T, Kazita K, Chokyu K, Mima T, Mori K: Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 21: 249-254, 2000
14. Murdock DK, Hoffman MT, Logemann TN, Kaufman JS, Engelmeier RS: Coronary artery stenting during acute myocardial infarction in patients treated with IIb/IIIa anti-platelet antibodies: early outcome results. Wis Med J 95: 867-871, 1996
15. Nath FC, Muller DW, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ: Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 21: 622-627, 1993
16. Sick P, Huttl T, Niebauer J, Thiele H, Lauer B, Hambrecht R, Hentschel B, Schuler G: Influence of residual stenosis after percutaneous coronary intervention with stent implantation on development of restenosis and stent thrombosis. Am J Cardiol 91: 148-153, 2003
17. Wohrle J, Grebe OC, Nusser T, Al-Khayer E, Schaible S, Kochs M, Hombach V, Hoher M: Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation 107: 1840-1843, 2003
18. Yokote H, Terada T, Ryujin K, Konoshita Y, Tsuura M, Nakai E, Kamei I, Moriwaki H, Hayashi S, Itakura T: Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. Neuroradiology 40: 590-596, 1998